Caris Foundation announces $2.5 Million Commitment to Pink Ribbon-Red Ribbon Partnership

Gift will fund the management and coordination of the Partnership as well as offer discounted pathology

Irving, TX, September 16, 2011 – The Caris Foundation, a non-profit private foundation established in Irving, Texas, to aid impoverished people by helping provide for their basic needs, has announced a 2.5 million dollar commitment to the Pink Ribbon-Red Ribbon (PRRR) Partnership, in conjunction with Caris Life Sciences, Inc. This public-private initiative is led by the George W. Bush Institute, in collaboration with the U.S. Department of State, Susan G. Komen for the Cure® and UNAIDS.

The Caris Foundation and Caris Life Sciences will provide support for the management of the Pink Ribbon-Red Ribbon Partnership through a $2.5 million donation to fund the management and coordination of the Partnership.  In addition, Caris Life Sciences will provide discounted and in-kind anatomic pathology and molecular diagnostic services to ensure breast and cervical cancer patients are diagnosed early and given information about which therapies are likeliest to succeed in the treatment of their disease.

Introduced earlier this week, this new initiative will expand the availability of vital cervical and breast cancer screening and treatment for women at risk in developing nations in sub-Saharan Africa and Latin America. The cervical cancer screening and treatment services leverage the platform and resources of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), established initially under President Bush and continued as a cornerstone of President Obama’s Global Health Initiative (GHI).

“The Caris Foundation and Caris Life Sciences’ partnership with PRRR will make critical diagnostic tools available to women who are needlessly deprived of vital cervical and breast cancer screening and treatment,” stated Kathy Halbert, Co-founder of Caris Foundation.  “Promoting early and accurate diagnosis of breast and cervical cancer is absolutely critical to determining the most effective cancer treatment, and we applaud PRRR’s efforts to ensure appropriate treatment of these diseases earlier and with greater efficacy.  The Caris Foundation and Caris Life Sciences believe this partnership will help alleviate suffering for many women, and we are honored to play a vital role.”

About the Caris Foundation
The Caris Foundation is a private, Texas-based non-profit foundation established in Irving, Texas, in 2002 to aid impoverished people by helping provide for their basic needs. In doing so, the Foundation seeks to establish a local presence in communities in order to understand the people’s basic needs and implement solutions that are culturally relevant and sustainable.

About Caris Life Sciences
Caris Life Sciences, a leading biosciences company, specializes in the development and commercialization of the highest quality anatomic pathology, molecular profiling and blood-based diagnostic technologies, in the fields of oncology, dermatopathology, hematopathology, gastrointestinal pathology and urologic pathology. The company provides academic-caliber consultations for thousands of patients a day, through its industry-leading team of expert, subspecialty pathologists. Caris also offers advanced molecular analyses of patient samples through prognostic testing services and genomic, transcriptomic, and proteomic profiling to assist physicians in their treatment of cancer. Currently, Caris is developing a series of blood tests utilizing the patented Carisome™ platform — a proprietary, blood-based testing technology for diagnosis, prognosis, and theranosis of cancer and other complex diseases. The company is headquartered in the Dallas metroplex, and operates laboratories at the headquarters, as well as in the Phoenix and Boston metro areas.

# # #

Media Inquiries:

Holly Clark
Caris Life Sciences
214-596-7060
hclark@carisls.com